Delivery Order SPE2DB22D2206-SPE2DB26FDV18
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,368.90 to AmerisourceBergen Drug Corp for ALBUKED-25 VIAL 100ML pharmaceutical product on September 26, 2025, with completion expected by October 20, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded...
- The Defense Logistics Agency awarded a $1,320.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of ALBUKED-5 VIAL 250ML pharmaceutical products. The delivery order, which is a child action under a larger contract vehicle, has an ultimate completion date of August 7, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This non-competitive award reflects the ordering activity under an existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,368.90 to AmerisourceBergen Drug Corp for the supply of ALBUKED-25 vial 100ML on September 29, 2025, with an ultimate completion date of October 21, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency (DLA) awarded a $1,320.60 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Albuked-5 Vial 250ML, a pharmaceutical product. This is a firm fixed price contract with an ultimate completion date of October 7, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made without a set-aside designation through competitive procurement....
- The Defense Logistics Agency awarded a $1,140.75 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of ALBUKED-25 vials in 100ml quantities. This firm fixed-price contract, with an ultimate completion date of October 10, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation and will be performed at the contractor's facility in...
- The Defense Logistics Agency awarded a $1,131.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of ALBUKED-25 vial 50ML pharmaceutical product. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of August 1, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,062.47 to AmerisourceBergen Drug Corp on October 20, 2025, with an ultimate completion date of October 21, 2025. This contract is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which is also the headquarters of the prime contractor. This delivery order represents a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a $1,368.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically ALBUKED-25 VIAL 100ML, with performance in Conshohocken, Pennsylvania and an ultimate completion date of September 24, 2025. This non-set-aside competitive award was issued on September 3, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,980.90 to AmerisourceBergen Drug Corp for ALBUKED-5 VIAL 250ML, a pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and was awarded on August 5, 2025 without a set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which is also the headquarters location of AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,281.50 by the Defense Logistics Agency on September 18, 2025, with an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price contract calls for the delivery of Albuked-25 vial 100ml to support federal medical procurement needs. The delivery order is classified as a child contract under a larger indefinite delivery contract vehicle, reflecting...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDV18Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,320.60 to AmerisourceBergen Drug Corp for ALBUKED-5 VIAL 250ML on October 29, 2025, with an ultimate completion date of November 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a small-value pharmaceutical supply transaction under the company's existing contract vehicle with DLA. This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen leverages this prime IDC to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates consistent capability to fulfill competitive procurement requirements across multiple therapeutic domains, from brand-name and generic medications to specialized medical supplies and vaccines.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/29/25 |